JP2022538885A5 - - Google Patents

Info

Publication number
JP2022538885A5
JP2022538885A5 JP2021577914A JP2021577914A JP2022538885A5 JP 2022538885 A5 JP2022538885 A5 JP 2022538885A5 JP 2021577914 A JP2021577914 A JP 2021577914A JP 2021577914 A JP2021577914 A JP 2021577914A JP 2022538885 A5 JP2022538885 A5 JP 2022538885A5
Authority
JP
Japan
Prior art keywords
rodent
immunoglobulin
bovine
transgenic
gene segment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021577914A
Other languages
English (en)
Japanese (ja)
Other versions
JP7752536B2 (ja
JP2022538885A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/040290 external-priority patent/WO2021003152A1/en
Publication of JP2022538885A publication Critical patent/JP2022538885A/ja
Publication of JP2022538885A5 publication Critical patent/JP2022538885A5/ja
Priority to JP2025162945A priority Critical patent/JP2026026076A/ja
Application granted granted Critical
Publication of JP7752536B2 publication Critical patent/JP7752536B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021577914A 2019-07-01 2020-06-30 トランスジェニック哺乳動物およびその使用法 Active JP7752536B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025162945A JP2026026076A (ja) 2019-07-01 2025-09-30 トランスジェニック哺乳動物およびその使用法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962869415P 2019-07-01 2019-07-01
US62/869,415 2019-07-01
PCT/US2020/040290 WO2021003152A1 (en) 2019-07-01 2020-06-30 Transgenic mammals and methods of use thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025162945A Division JP2026026076A (ja) 2019-07-01 2025-09-30 トランスジェニック哺乳動物およびその使用法

Publications (3)

Publication Number Publication Date
JP2022538885A JP2022538885A (ja) 2022-09-06
JP2022538885A5 true JP2022538885A5 (https=) 2023-07-07
JP7752536B2 JP7752536B2 (ja) 2025-10-10

Family

ID=71846497

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021577914A Active JP7752536B2 (ja) 2019-07-01 2020-06-30 トランスジェニック哺乳動物およびその使用法
JP2025162945A Pending JP2026026076A (ja) 2019-07-01 2025-09-30 トランスジェニック哺乳動物およびその使用法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025162945A Pending JP2026026076A (ja) 2019-07-01 2025-09-30 トランスジェニック哺乳動物およびその使用法

Country Status (13)

Country Link
US (1) US20220369609A1 (https=)
EP (2) EP4567118A3 (https=)
JP (2) JP7752536B2 (https=)
CN (1) CN114554841B (https=)
AU (1) AU2020298458B2 (https=)
CA (1) CA3144958A1 (https=)
DK (1) DK3993623T3 (https=)
ES (1) ES3027509T3 (https=)
FI (1) FI3993623T3 (https=)
IL (1) IL289469A (https=)
PL (1) PL3993623T3 (https=)
PT (1) PT3993623T (https=)
WO (1) WO2021003152A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3476942T3 (da) 2017-10-27 2022-04-19 Trianni Inc Lange kimlinje-dh-gener og antistoffer med lang hcdr3
WO2022235759A1 (en) * 2021-05-05 2022-11-10 Trianni, Inc. Transgenic rodents expressing chimeric equine-rodent antibodies and methods of use thereof
US20250320520A1 (en) 2021-10-01 2025-10-16 Abcellera Biologics Inc. Trangenic rodents for cell line identification and enrichment
KR20240110577A (ko) * 2021-11-10 2024-07-15 트리아니, 인코포레이티드 유전자이식 포유동물 및 이의 사용 방법
JP7748680B2 (ja) * 2021-11-16 2025-10-03 国立大学法人鳥取大学 改変d領域を含むヒト免疫グロブリン重鎖遺伝子座を有する哺乳動物人工染色体ベクター、及びそのベクターを保持する細胞又は非ヒト動物

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1293460C (en) 1985-10-07 1991-12-24 Brian Lee Sauer Site-specific recombination of dna in yeast
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
US5175384A (en) 1988-12-05 1992-12-29 Genpharm International Transgenic mice depleted in mature t-cells and methods for making transgenic mice
GB8904009D0 (en) 1989-02-22 1989-04-05 Celltech Ltd Vector
US5464764A (en) 1989-08-22 1995-11-07 University Of Utah Research Foundation Positive-negative selection methods and vectors
US6689610B1 (en) 1989-08-22 2004-02-10 University Of Utah Research Foundation Cells and non-human organisms containing predetermined genomic modifications and positive-negative selection methods and vectors for making same
US6673986B1 (en) 1990-01-12 2004-01-06 Abgenix, Inc. Generation of xenogeneic antibodies
US5877397A (en) 1990-08-29 1999-03-02 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
US5814318A (en) 1990-08-29 1998-09-29 Genpharm International Inc. Transgenic non-human animals for producing heterologous antibodies
US5874299A (en) 1990-08-29 1999-02-23 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5661016A (en) 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
US7041871B1 (en) 1995-10-10 2006-05-09 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5789650A (en) 1990-08-29 1998-08-04 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
DE69133557D1 (de) 1990-08-29 2007-03-15 Pharming Intellectual Pty Bv Homologe rekombination in säugetier-zellen
WO1992015694A1 (en) 1991-03-08 1992-09-17 The Salk Institute For Biological Studies Flp-mediated gene modification in mammalian cells, and compositions and cells useful therefor
DE4228162C1 (de) 1992-08-25 1994-01-13 Rajewsky Klaus Dr Verfahren zum Ersetzen homologer Genabschnitte aus Säugern in der Keimbahn von nicht-menschlichen Säugern
US5593598A (en) 1994-04-20 1997-01-14 Mcginness; Michael P. Method and apparatus for closed loop recycling of contaminated cleaning solution
US6130364A (en) 1995-03-29 2000-10-10 Abgenix, Inc. Production of antibodies using Cre-mediated site-specific recombination
US6091001A (en) 1995-03-29 2000-07-18 Abgenix, Inc. Production of antibodies using Cre-mediated site-specific recombination
CA2722378C (en) 1996-12-03 2015-02-03 Amgen Fremont Inc. Human antibodies that bind tnf.alpha.
US6774279B2 (en) 1997-05-30 2004-08-10 Carnegie Institution Of Washington Use of FLP recombinase in mice
FR2814642B1 (fr) 2000-10-03 2005-07-01 Ass Pour Le Dev De La Rech En Souris transgenique pour la recombinaison ciblee mediee par la cre-er modifiee
US6596541B2 (en) 2000-10-31 2003-07-22 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US20080184380A1 (en) * 2004-10-22 2008-07-31 Therapeutic Human Polyclonals Inc. Suppression of Endogenous Immunoglobulin Expression in Non-Human Transgenic Animals
US7422889B2 (en) 2004-10-29 2008-09-09 Stowers Institute For Medical Research Dre recombinase and recombinase systems employing Dre recombinase
JP5827127B2 (ja) * 2008-12-18 2015-12-02 エラスムス・ユニヴァーシティ・メディカル・センター・ロッテルダム ヒト化抗体を発現する非ヒトトランスジェニック動物及びその使用
PT3034608T (pt) * 2010-06-22 2019-05-28 Regeneron Pharma Ratinhos expressando uma cadeia leve híbrida de imunoglobulina com uma região variável humana
US10793829B2 (en) * 2010-07-26 2020-10-06 Trianni, Inc. Transgenic mammals and methods of use thereof
CN103025884B (zh) 2010-07-26 2015-11-25 特里安尼公司 转基因动物和使用方法
SG10201605675WA (en) * 2011-12-20 2016-09-29 Regeneron Pharma Humanized light chain mice
US9788534B2 (en) * 2013-03-18 2017-10-17 Kymab Limited Animal models and therapeutic molecules
SG10201913483XA (en) * 2016-11-04 2020-03-30 Regeneron Pharma Non-human animals having an engineered immunoglobulin lambda light chain locus
HUE060608T2 (hu) * 2017-12-05 2023-03-28 Regeneron Pharma Genetikailag módosított immunglobulin lambda könnyûlánccal rendelkezõ egerek és azok alkalmazása

Similar Documents

Publication Publication Date Title
JP2022538886A5 (https=)
JP2022538885A5 (https=)
AU2021200079B2 (en) Animal models and therapeutic molecules
JP5827127B2 (ja) ヒト化抗体を発現する非ヒトトランスジェニック動物及びその使用
ES2576928T3 (es) Ratones que expresan una cadena ligera con las regiones variable lambda humana y constante de ratón
JP2021505141A5 (https=)
CN114763558B (zh) 重组基因组、非人哺乳动物细胞及其产生方法和用途
Schusser et al. Harnessing gene conversion in chicken B cells to create a human antibody sequence repertoire
JP2019521668A5 (https=)
CA3046559A1 (en) Vhh-containing heavy chain antibody and production thereof
JP2024543248A5 (https=)
RU2025113765A (ru) Грызуны, экспрессирующие общую легкую цепь
JPWO2023090361A5 (https=)
NZ749707A (en) Non-human animals expressing exogenous terminal deoxynucleotidyltransferase
JP2024516996A5 (https=)
HK40058708A (en) Rodent models and therapeutic molecules
HK40058709B (en) Rodent models and therapeutic antibodies
NZ749707B2 (en) Non-human animals expressing exogenous terminal deoxynucleotidyltransferase
HK40075382A (en) Rodent models and therapeutic antibodies
HK1184966A (en) Animal models and therapeutic molecules
HK1231692B (en) Non-human animals that make single domain binding proteins
HK1172207B (en) Animal models and therapeutic molecules